BCM
CLBT icon

Bienville Capital Management’s Cellebrite CLBT Stock Holding History

Bienville Capital Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-957,000
Closed -$7.67M – 146
2021
Q4 		$7.67M Buy
+957,000
New +$9.01M 5.55% 4

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $903M AUM 113.12% 1-Year Est. Return
IP
Isomer Partners New York $74.3M AUM 23.95% 1-Year Est. Return
CIBC Asset Management
CIBC Asset Management Toronto, Ontario, Canada $45.6B AUM 44.74% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
CC
Crosslink Capital Menlo Park, California $1.35B AUM 35.86% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
MCM
Makena Capital Management Menlo Park, California $952M AUM 13.93% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Bienville Capital Management's CLBT Position: Q1 2022 in Review

Bienville Capital Management sold out of Cellebrite (CLBT) in Q1 2022, closing a stake of 957,000 shares — an estimated $7.67M sold.

Bienville Capital Management first reported a position in CLBT in Q4 2021 and held it in 1 quarter. The position peaked at $7.67M in Q4 2021. 49 funds tracked by Wall St. Rank hold CLBT as of Q1 2022.

  • Bienville Capital Management reported no remaining Cellebrite position as of Q1 2022 after selling out during the quarter.
  • Bienville Capital Management sold 957,000 Cellebrite shares in Q1 2022, an estimated $7.67M.
  • Bienville Capital Management first reported a position in Cellebrite in Q4 2021 and held it in 1 quarter.
  • Bienville Capital Management's Cellebrite position peaked at $7.67M in Q4 2021.
  • 49 funds tracked by Wall St. Rank held Cellebrite as of Q1 2022.

Based on Bienville Capital Management's 13F filing for Q1 2022, filed 16 May 2022.